Sara Bringhen, MD, PhD¹, Elisabetta Antonioli, MD^2*, Barbara Gamberi, MD^3*, Benedetto Bruno, MD, PhD^4,5, Daniele Derudas^6*, Patrizia Tosi, MD^7*, Francesca Fazio, MD, PhD^8*, Rita Mazza, MD^9*, Sonia Ronconi, MD^10*, Paolo Corradini, MD¹¹, Flavia Lotti, MD^12*, Claudia Cellini, MD, PhD^13*, Antonietta Pia Falcone, MD, PhD^14*, Piero Galieni, MD^15*, Roberto Ria, MD^16*, Angelo Belotti, MD^17*, Donato Mannina, MD^18*, Anna Maria Cafro, MD^19*, Clotilde Cangialosi, MD^20*, Iolanda Donatella Vincelli, MD^21*, Alessandra Lombardo, MD^22*, Alessandra Larocca, MD, PhD^1,5, Mario Boccadoro, MD²³ and Mattia D'Agostino, MD^4,5*

¹SSD Clinical Trial in Oncoematologia e Mieloma Multiplo, Department of Oncology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy
²Hematology Unit, AOU Careggi, Florence, Italy
³Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy
⁴Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy
⁵Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy
⁶SC di Ematologia e CTMO, Ospedale Oncologico di Riferimento Regionale "A. Businco", ARNAS "G. Brotzu", Cagliari, Italy
⁷UO Ematologia, Ospedale di Rimini, Rimini, Italy
⁸Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
⁹Department of Oncology and Hematology, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Italy
¹⁰IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy
¹¹University of Milan. Hematology Division, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
¹²Sezione di Ematologia e Immunologia Clinica, Ospedale Santa Maria della Misericordia, località Sant’Andrea delle Fratte, Perugia, Italy
¹³AUSL Romagna, U.O.C. Ematologia, Ospedale Santa Maria delle Croci, Ravenna, Italy
¹⁴Hematology, IRCCS "Casa Sollievo della Sofferenza" Hospital, San Giovanni Rotondo, Italy
¹⁵UOC Ematologia e Terapia cellulare, Ospedale C. e G. Mazzoni, Ascoli Piceno, Italy
¹⁶Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Aldo Moro Medical School, Bari, Italy
¹⁷Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
¹⁸Oncology-Hematology Department, Papardo Hospital, Messina, Italy
¹⁹SC Ematologia, ASST GOM Niguarda, Milano, Italy
²⁰U.O.C. Ematologia, A.O. Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
²¹Hematology Unit, Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy
²²S.C. di Oncoematologia, A.O. Santa Maria di Terni, Terni, Italy
²³European Myeloma Network, EMN, Italy

Omar Nadeem, MD¹, Sophie Magidson, BS^1*, Shonali Midha, MD, BS^1*, Elizabeth K. O'Donnell, MD¹, Monique A Hartley-Brown, MD², Adam S. Sperling, MD, PhD¹, Robert A. Redd, MS^3*, Marjorie Marto^1*, Christine Davie^1*, Caroline Ricciardi^1*, Dechen Choden^1*, Ashlee Strutevant^1*, Jillian Alberti^1*, Clifton C. Mo, MD¹, Jacob Laubach⁴, Paul G. Richardson, MD¹, Kenneth C. Anderson, MD⁵, Nikhil C Munshi, MD^1*, Lorenzo Trippa^1* and Irene M. Ghobrial, MD¹

¹Dana-Farber Cancer Institute, Boston, MA
²DFCI, Boston, MA
³Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁴Dana-Farber/Partners CancerCare, Harvard Medical School, Boston, MA
⁵Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Cyrille Touzeau, MD, PhD^1*, Aurore Perrot, MD, PhD^2*, Cyrille Hulin, MD^3*, Salomon Manier, MD, PhD⁴, Margaret Macro, MD^5*, Marie-Lorraine Chretien, MD^6*, Lionel Karlin^7*, Olivier Decaux, MD, PhD^8*, Caroline Jacquet, MD^9*, Mourad Tiab, MD^10*, Xavier Leleu, MD¹¹, Jill Corre, PharmD, PhD^12*, Alexandra Jobert^13*, Lucie Planche^14*, Herve Avet-Loiseau, MD, PhD^15* and Philippe Moreau, MD, PhD^16*

¹Centre Hospitalier Universitaire de Nantes, Nantes, France
²Toulouse, and CRCT, Toulouse, France, Toulouse, France
³Centre Hospitalier Universitaire de Bordeaux, Pessac Cedex, FRA
⁴Centre Hospitalier Universitaire - Hôpital Huriez, Lille, France
⁵Hopital Cote De Nacre, Caen, France
⁶CHU Dijon, DIJON, FRA
⁷CH Lyon Sud, Pierre Benite Cedex, FRA
⁸Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou, Rennes, France
⁹CHU de Nancy, Vandoeuvre Les Nancy, FRA
¹⁰Centre Hospitalier Departemental, La Roche Sur Yon Cedex 9, FRA
¹¹Service D'Hématologie Et Thérapie Cellulaire, Poitiers, France
¹²Institut universitaire du cancer de Toulouse Oncopole,, Toulouse, France
¹³Centre Hospitalier Universitaire, Nantes, France
¹⁴Chu Nantes, Nantes, FRA
¹⁵Institut universitaire du cancer de Toulouse Oncopole, Toulouse, France
¹⁶Hematology Clinic, University Hospital Hotel-Dieu, Nantes, France

Niels W.C.J. van de Donk, MD, PhD¹, Cyrille Touzeau, MD, PhD^2*, Evangelos Terpos, MD, PhD³, Aurore Perrot, MD, PhD^4*, Roberto Mina, MD^5,6*, Maaike de Ruijter, MANP, MSc^7*, Elisabetta Antonioli, MD^8*, Eirini Katodritou, MD^9*, Norbert Pescosta, MD^10*, Paulus A.F. Geerts, MD, PhD^11*, Cécile Sonntag, MD^12*, Ruth Wester, MD^13*, Angelo Belotti, MD^14*, Silvia Mangiacavalli, MD^15*, Massimo Offidani, MD^16*, Mattia D'Agostino, MD^5,6*, Mark van Duin, PhD^13*, Michele Cavo, MD^17*, Sara Aquino, MD, PhD^18*, Alessandra Lombardo, MD^19*, Mark-David Levin, MD, PhD²⁰, Cyrille Hulin, MD^21*, Mario Boccadoro, MD²², Pieter Sonneveld, MD, PhD^13* and Francesca Gay, MD, PhD^5,6

¹Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, Netherlands
²Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France
³Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁴Service d’Hématologie, CHU de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Université de Toulouse, Toulouse, France
⁵Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy
⁶Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy
⁷Amsterdam UMC, VUmc, Department of Hematology, Amsterdam, Netherlands
⁸Hematology Unit, AOU Careggi, Florence, Italy
⁹Theagenion Cancer Hospital, Thessaloniki, Greece
¹⁰Reparto Ematologia e TMNO, Ospedale Provinciale Bolzano, Bolzano, Italy
¹¹Isala Klinieken, Zwolle, Netherlands
¹²University Hospital, Hôpital Hautepierre, Strasbourg, France
¹³Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
¹⁴Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
¹⁵Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
¹⁶AOU delle Marche, Ancona, Italy
¹⁷IRCCS Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology and the Department of Medical and Surgical Sciences, Bologna University School of Medicine, Bologna, Italy
¹⁸Ematologia e Terapie cellulari, IRCCS Ospedale Policlinico San Martino, Genova, Italy
¹⁹A.O. Santa Maria di Terni – Università degli Studi di Perugia, Terni–Perugia, Italy
²⁰Albert Schweitzer hospital, Dordrecht, Netherlands
²¹Centre Hospitalier Universitaire Bordeaux, Bordeaux, France
²²European Myeloma Network, EMN, Italy

Maria-Victoria Mateos^1,2, Bruno Paiva^3*, Maria Teresa Cedena Romero, MD, PhD^4*, Noemi Puig, MD, PhD⁵, Anna Maria Sureda Balari, MD, PhD⁶, Albert Oriol^7*, Enrique M Ocio, MD, PhD⁸, Laura Rosiñol, MD, PhD^9*, Yolanda González-Montes, MD^10*, Juan Jose Bargay, MD^11*, Esther Gonzalez Garcia, MD^12*, Miguel Teodoro Hernández Garcia, MD, PhD^13*, Angel Ramirez, MD^14*, Alexia Suarez-Cabrera, MD, PhD^15*, María-Jesús Blanchard^16*, Sebastián Garzón, MD^17*, Luis Felipe Casado Montero, MD¹⁸, Valentin Cabanas Perianes, MD^19*, Jaime Pérez De Oteyza, MD, PhD^20*, Mercedes Gironella^21*, Joaquin Martinez-Lopez, MD, PhD^22*, Ana-Isabel -Teruel, MD, PhD^23*, Pilar Delgado, MD, PhD^24*, Elena Prieto, MD, PhD^25*, Juan Jose Lahuerta Palacios^4*, Joan Bladé, MD, PhD^26* and Jesus San Miguel^3*

¹Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBASL), Centro de Investigación del Cáncer (IBMCC-USAL,CSIC), Salamanca, Spain
²University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain
³Cancer Center Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBER-ONC number CB16/12/00369 and CB16/12/00489, Pamplona, Spain
⁴Hospital Universitario 12 de Octubre, CIBER-ONC CB16/12/00369, CNIO, Madrid, Spain
⁵Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain
⁶Clinical Hematology, Instituto Catalán de Oncología, L'Hospitalet De Llobregat, IDIBELL, Universitat de Barcelona, Barcelona, Spain
⁷Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain
⁸Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain
⁹Hematopoietic Cell Transplantation Unit,, Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain
¹⁰Institut d'Oncologia Dr. Josep Trueta, Girona, Spain
¹¹Hematology, Hospital Universitario Son LLatzer, IdIsBa, Palma de Mallorca, Spain
¹²University Hospital Cabueñes, Gijón, Spain
¹³Hospital Universitario de Canarias, Tenerife, Spain
¹⁴Hematology, Hospital Central de Asturias, Oviedo, Spain
¹⁵Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas De Gran Canaria, Spain
¹⁶Hematology, Hospital Universitario Ramon y Cajal, Madrid, Spain
¹⁷Hematology, Hospital Universitario De Jerez, Jerez De La Frontera, Spain
¹⁸Hospital General Universitario de Toledo, Toledo, Spain
¹⁹Department of Hematology, IMIB-Virgen de la Arrixaca University Hospital. University of Murcia., Murcia, Spain
²⁰Hematology, Hospital Universitario HM Sanchinarro, Madrid, Spain
²¹Hospital Universitari Vall d'Hebron, Barcelona, Spain
²²Hospital Universitario 12 de Octubre, I+12, CNIO, Complutense University, CIBERONC, Madrid, Spain
²³Hematology, Hospital Clínico Universitario de Valencia, Valencia, Spain
²⁴Hematology, Hospital Universitario Miguel Servet, Zaragoza, Spain
²⁵Hematology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
²⁶Hospital Clínic de Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona and GEM/PETHEMA, Barcelona, Spain

Ola Landgren, MD¹, Ajai Chari, MD^2*, Yael C. Cohen^3*, Andrew Spencer, MBBS, MD, FRACP, FRCPA^4*, Peter M. Voorhees, MD⁵, Irwindeep Sandhu^6*, Matthew W. Jenner^7*, Dean Smith^8*, Michele Cavo, MD^9*, Niels W.C.J van de Donk, MD, PhD^10*, Meral Beksac, MD¹¹, Philippe Moreau, MD, PhD^12*, Hartmut Goldschmidt¹³, Linlin Sha, PhD^14*, Liang Li^14*, Els Rousseau^15*, Robyn Dennis^16*, Robin Carson, MD, BA¹⁷ and Craig C. Hofmeister, MD¹⁸

¹Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, Miami, FL
²Icahn School of Medicine at Mount Sinai, New York, NY
³Department of Hematology, Tel-Aviv Sourasky (Ichilov) Medical Center, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
⁴Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, VIC, Australia
⁵Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
⁶Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
⁷University Hospital Southampton, Southampton, United Kingdom
⁸Department of Clinical Haematology, Nottingham University Hospitals, Nottinghamshire, United Kingdom
⁹IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy
¹⁰Department of Hematology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
¹¹Ankara University, Ankara, Turkey
¹²Hematology Department, University Hospital Hôtel-Dieu, Nantes, France
¹³GMMG-Study Group at University Hospital Heidelberg, Internal Medicine V, Heidelberg, Germany
¹⁴Janssen Research & Development, LLC, Shanghai, China
¹⁵Janssen Research & Development, Beerse, Belgium
¹⁶Janssen Research & Development, LLC, Raritan, NJ
¹⁷Janssen Research & Development, LLC, Spring House, PA
¹⁸Department of Hematology & Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA